HemaCare Posts $165,700 Loss in 2nd Quarter
- Share via
HemaCare Corp., a Sherman Oaks provider of blood products and therapeutic services, said it lost $165,700 in the second quarter that ended June 30 on record quarterly revenues of $1.9 million.
For the same period last year, HemaCare had a $296,000 loss. Revenues in the second quarter last year were $1.55 million.
HemaCare said the latest loss included $279,000 in expenses for its Passive Hyperimmune Therapy AIDS research project and a loss of $38,000 from the sale of certain assets of its clinical lab business.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
